Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Mechanisms of extracorporeal shock wave therapy in burn scar repair: Advances in immunoactivation-based scar remodeling research

Jin Y., Meng Z., Qin Z., Zhu J., Hong L., Shao W.

Narrative Review on Scar, Chronic Inflammation, published in Regen Ther (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Regen Ther (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40584815
PMCID
PMC12205553
DOI
10.1016/j.reth.2025.05.010
Citations
1

Abstract (original English)

Extracorporeal Shock Wave Therapy (ESWT) plays a key role in burn scar treatment through its immunoregulatory effects, influencing inflammation, fibrosis remodeling, and angiogenesis. These mechanisms collectively mediate scar repair, highlighting the importance of ESWT in restoring tissue homeostasis. However, its clinical efficacy depends on precise optimization of parameters such as energy flux density, pulse frequency, and treatment duration. Without proper adjustments, its therapeutic potential may be limited. This review systematically explores ESWT-mediated immunoregulation in scar formation and repair, addressing its impact on inflammatory responses, tissue fibrosis, and abnormal angiogenesis. Furthermore, we discuss challenges in optimizing treatment parameters, developing personalized strategies, and enhancing clinical translation. By focusing on immunoactivation signaling pathways, this review provides mechanistic insights into ESWT's role in burn scar management and underscores its potential for precision therapy. Ultimately, it offers a theoretical foundation and practical guidance for advancing standardized clinical applications of ESWT.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research